E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma

Blood Cancer J. 2023 Apr 7;13(1):48. doi: 10.1038/s41408-023-00828-4.

Mina Maksimos^{1

2}, Barbara Muz¹, John L Magnani³, Abdel Kareem Azab^{4

5}

¹ Department of Radiation Oncology, Cancer Biology Division, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
² Institute of Microbiology, Friedrich Schiller University, Jena, Germany.
³ GlycoMimetics Inc., Rockville, MD, USA.
⁴ Department of Radiation Oncology, Cancer Biology Division, Washington University in St. Louis School of Medicine, St. Louis, MO, USA. abdelkareem.azab@utsouthwestern.edu.
⁵ Department of Biomedical Engineering, The University of Texas Southwestern Medical Center, Dallas, TX, USA. abdelkareem.azab@utsouthwestern.edu.

No abstract available

Publication types